Open Access
Science advances, volume 6, issue 30
Shattering barriers toward clinically meaningful MSC therapies
Oren Levy
1
,
Rui Kuai
1, 2
,
Erika MJ Siren
1
,
Deepak Bhere
2, 3
,
Milton Yuka
1
,
Nabeel Nissar
3
,
Michael De Biasio
1
,
Martina Heinelt
1
,
Brock Reeve
4
,
Reza Abdi
5
,
Meshael Alturki
6, 7
,
Mohanad Fallatah
7
,
Abdulaziz Almalik
6, 7
,
Ali H. Alhasan
6, 7
,
KHALID SHAH
2, 3, 4
,
Jeffrey M. Karp
1, 2, 4, 8
Publication type: Journal Article
Publication date: 2020-07-24
PubMed ID:
32832666
Multidisciplinary
Abstract
To realize the potential of MSCs, bioengineering is needed to boost potency and control heterogeneity.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.